February 19, 2026

NMQF 40 Under 40 Leaders in Minority Health Introduction

NMQF 40 Under 40 Leaders in Minority Health: Why the program was introduced—and why it matters in 2026

Health Equity Events / Subash Kafle

The NMQF 40 Under 40 Leaders in Minority Health program spotlights rising professionals from minoritized communities who are working to strengthen minority health outcomes and expand health access—often while navigating […]

NMQF 40 Under 40 Leaders in Minority Health: Why the program was introduced—and why it matters in 2026 Read More »

Prescription pill bottles displayed in a pharmacy, representing changes in U.S. drug pricing policy under the Inflation Reduction Act and its potential impact on innovation and patient access.

How the Inflation Reduction Act Could Affect Drug Innovation, Biosimilars, and Patient Access

BIPOC News, Health Policy, Top Stories / Victor Mejia

WASHINGTON — The Inflation Reduction Act (IRA), passed in 2022, changed the way the federal government handles prescription drug prices. The law allows Medicare to negotiate the price of certain

How the Inflation Reduction Act Could Affect Drug Innovation, Biosimilars, and Patient Access Read More »